Sanara MedTech Inc. SMTI Conversion Of Note Receivable Into Equity Method Investment
Conversion Of Note Receivable Into Equity Method Investment at other companies
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept SMTI:ConversionOfNoteReceivableIntoEquityMethodInvestment.
The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sanara MedTech Inc.'s conversion of note receivable into equity method investment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sanara MedTech Inc.'s conversion of note receivable into equity method investment?
- Sanara MedTech Inc. (SMTI) reported conversion of note receivable into equity method investment of $1.1M in Q1 2025.
- What does conversion of note receivable into equity method investment mean?
- Reflects the non-cash conversion of a debt instrument (note receivable) into an equity interest in another entity. This indicates a strategic shift from a creditor position to an ownership or partnership stake in an investee.